Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07068880 · ClinicalTrials.gov registry record
Clinical Analysis of a Novel Flexor Tendon Repair Technique
A clinical trial of Flexor Tendon Laceration, sponsored by Brett Lewellyn.
- Recruiting
- Registry status
- 128
- Enrollment target
- 1
- Study location
NCT07068880: Recruiting study of Flexor Tendon Laceration, sponsored by Brett Lewellyn.
NCT07068880 is a study of Flexor Tendon Laceration that is actively recruiting participants, run by Brett Lewellyn. The registered enrollment target is 128 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07068880, a study of Flexor Tendon Laceration, is actively recruiting participants, sponsored by Brett Lewellyn.
- RECRUITING
- Registry status
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research study is to determine the efficacy and efficiency of two tendon repair techniques: the CoNextions tendon repair device vs a standard of care, L-O (Lew-Omar), suture repair technique. The investigators will also determine if there are similar or different rates of complications and failures via both objective and subjective measures.
Conditions Studied
Study Locations (1)
Florida
- Orlando Health - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2027-07 |
What NCT07068880 shows while recruiting
NCT07068880 is an observational study that tracks outcomes without assigning an intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Flexor Tendon Laceration appearing as the primary indexed condition, and to 0 interventions.
NCT07068880 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07068880 about?
NCT07068880 is a clinical study titled "Clinical Analysis of a Novel Flexor Tendon Repair Technique". The purpose of the research study is to determine the efficacy and efficiency of two tendon repair techniques: the CoNextions tendon repair device vs a standard of care, L-O (Lew-Omar), suture repair technique. The investigators will also determine if there are similar or different rates of complica...
What is the current status of trial NCT07068880?
This trial is currently recruiting. The enrollment target is 128 participants. The study started on 2024-06-18. Estimated completion is 2027-07.
What conditions does trial NCT07068880 study?
This clinical trial studies the following conditions: Flexor Tendon Laceration.
Who is sponsoring clinical trial NCT07068880?
This trial is sponsored by Brett Lewellyn, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07068880 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI